TrialOxidative medicine and cellular longevity2016
Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease.
Piotr Bartnicki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.